Structure and function of ligands for novel oxidized-LDL receptors in endothelial cell

内皮细胞中新型氧化LDL受体配体的结构和功能

基本信息

项目摘要

Ross's "the response-to-injury hypothesis of atherosclerosis" in the development of atherosclerosis is commonly accepted. Scavenger receptors mediate the endocytosis of chemically modified lipoproteins, such as acetylated low-density lipoprotein (Ac-LDL) and oxidized LDL (Ox-LDL), and have been implicated in the most important role for the hypothesis. The cDNAs of scavenger receptor gene family have been cloned and. its structures were deduced. LOX-1, a major receptor of oxidized LDL, SREC (scavenger receptor expressed by endothelial cell) cloned by expression cloning from human umbilical vein endothelial cells and CD36 are expressed in endothelial cells. These scavenger receptors recognize several negatively charged molecule such as modified lipoproteins and apoptic cells, and suggested for some roles in various diseases.We cloned a novel scavenger receptor termed FEEL-1 expressed in endothelial cells that was structurally unrelated to other scavenger receptors by expression cloning. The cloned receptor contained fasciclin (Fas-1), EGF-like, laminin-type EGF-like and link domains. Based on the domain structures, we temporary termed it FEEL-1 (fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor-1). Database search suggested the presence of a paralogous gene of FEEL-1, the full-length cDNA of this gene was also cloned and its nucleotide sequence was determined. The deduced amino acid sequence of the clone indicated that its domain organization is similar to FEEL-1 and we termed this clone FEEL-2. The receptor had binding activity to cells of both Gram-positive and Gram-negative bacteria and advaned glycation end product. Moreover, in vitro tube formation assay suggested that the receptor might play a role in angiogenesis. These results suggest that FEELs play important roles in the defense mechanisms against bacterial infection, atherosclerosis and diabet.
Ross的“动脉粥样硬化损伤反应假说”在动脉粥样硬化的发展中被普遍接受。清道夫受体介导化学修饰的脂蛋白,如乙酰化低密度脂蛋白(Ac-LDL)和氧化LDL(Ox-LDL)的内吞作用,并已被牵连在最重要的作用的假说。清道夫受体基因家族的cDNA已被克隆,推测了其结构。氧化LDL的主要受体LOX-1、通过表达克隆从人脐静脉内皮细胞克隆的SREC(scavenger receptor expressed by endothelial cell)和CD 36在内皮细胞中表达。这些清道夫受体识别几种带负电荷的分子,例如修饰的脂蛋白和凋亡细胞,并暗示在各种疾病中发挥某些作用。我们通过表达克隆克隆了一种在内皮细胞中表达的新型清道夫受体FEEL-1,该受体在结构上与其他清道夫受体无关。克隆的受体包含fasciclin(Fas-1),EGF样,层粘连蛋白型EGF样和连接结构域。基于结构域的结构,我们暂时将其命名为FEEL-1(fasciclin,EGF-like,lamininin-type EGF-like and link domain-containing scavenger receptor-1)。通过数据库检索发现FEEL-1基因存在旁系同源基因,并克隆了该基因的全长cDNA,测定了其核苷酸序列。推导的氨基酸序列表明,该克隆的结构域组织类似于FEEL-1,我们将其命名为FEEL-2。该受体对革兰氏阳性菌和革兰氏阴性菌的细胞都有结合活性,并能抑制糖基化终产物。体外小管形成实验表明,该受体可能在血管生成中发挥作用。这些结果表明FEEL在抵抗细菌感染、动脉粥样硬化和糖尿病的防御机制中起重要作用。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tamura, Y., Adachi, H., et al.: "FEEL-1 and FEEL-2 are endocytic receptors for advanced glycation end products"J.Biol.Chem.published Dec 3, 2002 as 10.1074/jbc. M210211200. (2002)
Tamura,Y.,Adachi,H.等人:“FEEL-1和FEEL-2是晚期糖基化终产物的内吞受体”J.Biol.Chem.published于2002年12月3日作为10.1074/jbc。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Fujioka, T., Kim, J.H., Adachi, H., Saito, K., Tsujimoto, M., Yokoyama, S., Ui, M.: "Further evidence for the involvement of insulin receptor substrates in epidermal growth factor-induced activation of phosphatidylinositol 3-kinase."Eur. J. Biochem.. 268.
Fujioka, T.、Kim, J.H.、Adachi, H.、Saito, K.、Tsujimoto, M.、Yokoyama, S.、Ui, M.:“胰岛素受体底物参与表皮生长因子诱导的进一步证据
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ishii J, Adachi H, et al.: "SREC-II, a new member of the scavenger receptor type F family, trans-interacts with SREC-I through its extracellular domain"J.Biol.Chem.. 277. 39696-39702 (2002)
Ishii J、Adachi H 等人:“SREC-II,F 型清道夫受体家族的新成员,通过其胞外结构域与 SREC-I 反式相互作用”J.Biol.Chem.. 277. 39696-39702
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ishii J, Adachi H, Aoki J, Koizumi H, Tomita S, Suzuki T, Tsujimoto M, Inoue K, Arai H: "SREC-II, a new member of the scavenger receptor type F family, trans-interacts with SREC-I through its extracellular domain"J. Biol. Chem.. 277. 39696-39702 (2002)
Ishii J、Adachi H、Aoki J、Koizumi H、Tomita S、Suzuki T、Tsujimoto M、Inoue K、Arai H:“SREC-II 是 F 型清道夫受体家族的新成员,与 SREC-I 存在反式相互作用
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ishli J, Adachi, H., et al.: "SREC-II, a new member of the scavenger receptor type F family, transinteracts with SREC-I through its extracellular domain"J.Biol.Chem.. 277. 39696-39702 (2002)
Ishli J、Adachi、H. 等人:“SREC-II 是 F 型清道夫受体家族的新成员,通过其胞外结构域与 SREC-I 发生反式相互作用”J.Biol.Chem.. 277. 39696-39702
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ADACHI Hideki其他文献

ADACHI Hideki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ADACHI Hideki', 18)}}的其他基金

Analysis for physical roles of scavenger receptor FEEL
清道夫受体FEEL的物理作用分析
  • 批准号:
    21590084
  • 财政年份:
    2009
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of the relation between multi-ligand receptor, FEEL and diseases
阐明多配体受体、FEEL与疾病之间的关系
  • 批准号:
    16390027
  • 财政年份:
    2004
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

RII Track-4: NSF: Developing 3D Models of Live-Endothelial Cell Dynamics with Application Appropriate Validation
RII Track-4:NSF:开发活内皮细胞动力学的 3D 模型并进行适当的应用验证
  • 批准号:
    2327466
  • 财政年份:
    2024
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Standard Grant
CAREER: Modulating endothelial cell function using targeted electrical stimulation
职业:使用靶向电刺激调节内皮细胞功能
  • 批准号:
    2338949
  • 财政年份:
    2024
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Continuing Grant
ERI: Biological Effects of Low-Frequency, Low-Intensity Ultrasound on Endothelial Cell and Macrophage Co-Culture
ERI:低频、低强度超声对内皮细胞和巨噬细胞共培养的生物学效应
  • 批准号:
    2347558
  • 财政年份:
    2024
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Standard Grant
Control of endothelial cell mechanics and blood vessel remodeling by blood flow
通过血流控制内皮细胞力学和血管重塑
  • 批准号:
    23K23887
  • 财政年份:
    2024
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Reverse translarional research based on cultured human corneal endothelial cell injection therapy
基于培养人角膜内皮细胞注射疗法的反向翻译研究
  • 批准号:
    23H03062
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Endothelial Cell Reprogramming in Familial Intracranial Aneurysm
家族性颅内动脉瘤的内皮细胞重编程
  • 批准号:
    10595404
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
General Capillary to Arterial Endothelial Cell Transition in Pulmonary Arterial Hypertension
肺动脉高压中毛细血管内皮细胞向动脉内皮细胞的转变
  • 批准号:
    10716738
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Role of endothelial cell senescence in age-related cardiomyopathy
内皮细胞衰老在年龄相关性心肌病中的作用
  • 批准号:
    10726050
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Altered microglia states and microglia-endothelial cell axis in relation to white matter disease progression in VCID
VCID 中小胶质细胞状态和小胶质细胞内皮细胞轴的改变与白质疾病进展相关
  • 批准号:
    10738860
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
MLL1 drives collaborative leukocyte-endothelial cell signaling and thrombosis after coronavirus infection
MLL1在冠状病毒感染后驱动白细胞-内皮细胞信号传导和血栓形成
  • 批准号:
    10748433
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了